About Event

Exosome Characterization & Analytical Development – What Is It About?

Across three days in April, this hotly anticipated summit will unite key experts from AbbVie, Aegle Therapeutics, Vesigen Therapeutics, and more to unite an industry on:

  • In depth technical content of exosome analysis and parameters for confidence in quality
  • Defining standardized tools and techniques while keeping regulatory guidance in mind for clinical progression
  • Bridging communications and networking between Analytical Experts and Decision Makers

Join Your Peers to:

HW231206 Exosome Based Characterization & Analytical Development Summit logo ICON

Discover novel data from pioneering companies to benchmark best practices and ensure exosomes are reaching their full potential

HW231206 Exosome Based Characterization & Analytical Development Summit logo ICON

Build your understanding of how key challenges should be tackled collaboratively, alongside how others are overcoming them with the use of new analytical tools

 

HW231206 Exosome Based Characterization & Analytical Development Summit logo ICON

Engage with your peers from large pharma and biotech companies to drive collaborative initiatives and cultivate impactful partnerships for longevity.

Who Will You Meet?

Join industry thought-leaders from Large Pharma, Biotech’s and Academia to collaborate on ideas and findings surrounding future clinical developments.

Seniority of Attendees Graph
Types of Companies Attending Graph

What Your Peers Have to Say

“The line-up of speakers and lots of new data presented made this conference especially worthwhile”

Astellas

“A space for most recent technology to be showcased to identify which companies are making machines, devices and equipment for characterising exosomes”

Vivasome